Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-24, Stock:PFE, The news for the past five days is as follows:
2019-01-16: NEWS1: Court rules against Pfizer in religious discrimination suit.NEWS2: Why Ligand Pharmaceuticals Tanked 25%.NEWS3: 6 Top Gainers In Healthcare Sector (BIOC, ALRN, VCNX...).NEWS4: 6 Top Gainers In Healthcare Sector (BIOC, ALRN, VCNX...).NEWS5: Is Pfizer a Buy?.NEWS6: Is Pfizer a Buy?.NEWS7: Health Care Sector Update for 01/16/2019: APTX, KTOV, STML, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 01/16/2019: APTX, KTOV, STML, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 17, 2019.NEWS10: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 17, 2019.NEWS11: Is Pfizer a Buy?.NEWS12: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS13: Fiserv to buy First Data in $22B all-stock deal.NEWS14: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS15: Pfizer (PFE) Gains But Lags Market: What You Should Know.
2019-01-17: NEWS1: The Stable Value Stock Is Built to Weather Market Storms.NEWS2: 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group.NEWS3: 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group.NEWS4: J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect.NEWS5: 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group.
2019-01-18: NEWS1: Top Stock Reports for Pfizer, Biogen & Schwab.NEWS2: Top Stock Reports for Pfizer, Biogen & Schwab.NEWS3: Top Stock Reports for Pfizer, Biogen & Schwab.NEWS4: Bulls bet on this biopharma company. Plus, the update on ....NEWS5: Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY.NEWS6: Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY.NEWS7: Baxter (BAX) Gains From Sharesource's Global Success Rates.NEWS8: Baxter (BAX) Gains From Sharesource's Global Success Rates.NEWS9: Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress.NEWS10: Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress.NEWS11: Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY.NEWS12: J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect.NEWS13: J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect.NEWS14: PFE's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'.NEWS15: PFE's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'.NEWS16: Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress.NEWS17: Baxter (BAX) Gains From Sharesource's Global Success Rates.
2019-01-22: NEWS1: All Signals Are Positive for Buying Abbott Laboratories.NEWS2: All Signals Are Positive for Buying Abbott Laboratories.NEWS3: How Pfizer’s Research Pipeline Is Set Up ahead of Its Q4 Results.NEWS4: Johnson & Johnson Releases Its 2018 Results: Revenue Up 6.7%.NEWS5: All Signals Are Positive for Buying Abbott Laboratories.NEWS6: Is Pfizer Expected to Impress the Market with Its Q4 Results?.NEWS7: Better Buy: Pfizer vs. AbbVie.NEWS8: Better Buy: Pfizer vs. AbbVie.NEWS9: What Do Analysts Recommend for Pfizer ahead of Its Q4 Results?.NEWS10: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS11: Better Buy: Pfizer vs. AbbVie.NEWS12: Will AVRO Reverse Course In Run-up To February Event?.NEWS13: Will AVRO Reverse Course In Run-up To February Event?.
2019-01-23: NEWS1: Big Pharma Stocks Were Downgraded by Analysts Today.NEWS2: Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook.NEWS3: MTUM, MRK, PFE, MA: ETF Outflow Alert.NEWS4: MTUM, MRK, PFE, MA: ETF Outflow Alert.NEWS5: Dow Movers: MRK, IBM.NEWS6: Dow Movers: MRK, IBM.NEWS7: Merck a Top Socially Responsible Dividend Stock With 2.9% Yield (MRK).NEWS8: Merck a Top Socially Responsible Dividend Stock With 2.9% Yield (MRK).NEWS9: Pfizer, Merck drop after Wall Street downgrades on &apos;patent cliff&apos; and competition.NEWS10: Pfizer, Merck drop after Wall Street downgrades on 'patent cliff' and competition.NEWS11: Is Pfizer Expecting a Rise in Its Expenses in 2019?.

Answer: Decrease